| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24a09549c32b46749d2d3e0f04f76eac |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-0017
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0051
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00781 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-00 |
| filingDate |
2008-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9fde14f62ff781a7387287729d87918f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eec32c7211979cc50241faeba5d323c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6201bf4b0d212c21aad5d4a575a432c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14dccc16dda3f720d0d3885c6a0e3780
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4cadfac3be4ab5cf46955d14704d164c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0bf85e0692622243dd168fcd668cce03 |
| publicationDate |
2012-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2459646-C2 |
| titleOfInvention |
Lachrymal opening inserts and method for therapeutic agent delivery |
| abstract |
FIELD: medicine. n SUBSTANCE: present invention refers to implanted ophthalmic devices for prolonged drug release in an eye, as well as to a method for making and using such devices. One version of the present invention refers to the device comprising: (a) a main portion accommodating a matrix consisting of prostaglandin and silicone; (b) a parylene coating on an external surface of the main portion; (c) one or more pores arranged on the end of the body which is closest to an anterior side of the eye wherein said pore extends from the external surface of the parylene coating to a surface of an upper portion of the body. n EFFECT: developing the implanted ophthalmic device for prolonged drug release in the eye. n 23 cl, 3 ex, 8 dwg |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2520834-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2557423-C1 |
| priorityDate |
2007-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |